136 related articles for article (PubMed ID: 29481890)
21. [Rational use of analgesics].
Dayer P
Rev Med Suisse Romande; 1996 Apr; 116(4):295-8. PubMed ID: 8693261
[No Abstract] [Full Text] [Related]
22. [Infection induced pain. What should be considered in analgesia? (interview by Dr. Andreas Hackel)].
Richter U
MMW Fortschr Med; 2009 Apr; 151(14):122-3. PubMed ID: 19504853
[No Abstract] [Full Text] [Related]
23. Drug allergy in mastocytosis.
Bonadonna P; Lombardo C
Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological treatment options for mast cell activation disease.
Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
[TBL] [Abstract][Full Text] [Related]
25. [Systemic mastocytosis].
Duché A
Presse Med; 1999 Nov; 28(35):1955-8. PubMed ID: 10598159
[TBL] [Abstract][Full Text] [Related]
26. Allergic conjunctivitis: Time for a new classification.
La Rosa M; Lionetti E; Reibaldi M; Longo A; Tomarchio S; Russo A; Gagliano C; Leonardi S; Avitabile T
Allergy Asthma Proc; 2015; 36(4):79-80. PubMed ID: 26108075
[No Abstract] [Full Text] [Related]
27. [Pain therapy in HIV patients].
Arendt G; Nolting T
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():16-8. PubMed ID: 19031560
[No Abstract] [Full Text] [Related]
28. Pharmacotherapeutic management of orofacial pain.
Crandall JA
Alpha Omegan; 2012; 105(3-4):82-5. PubMed ID: 23589948
[No Abstract] [Full Text] [Related]
29. Treatment of refractory mastocytic enterocolitis with budesonide.
Kuruvilla ME; Mathew S; Avadhani V
J Gastrointestin Liver Dis; 2018 Sep; 27(3):327-329. PubMed ID: 30240478
[TBL] [Abstract][Full Text] [Related]
30. Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome.
Asawa A; Simpson KH; Bonds RS
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):443-6. PubMed ID: 25868710
[No Abstract] [Full Text] [Related]
31. CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders.
Santos DD; Hatjiharissi E; Tournilhac O; Chemaly MZ; Leleu X; Xu L; Patterson C; Branagan AR; Manning RJ; Ho AW; Hunter ZR; Dimmock EA; Kutok JL; Churchill WH; Castells MC; Tai YT; Anderson KC; Treon SP
Clin Lymphoma Myeloma; 2006 May; 6(6):478-83. PubMed ID: 16796779
[TBL] [Abstract][Full Text] [Related]
32. Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis.
Ma Z; Tovar JP; Kwong KY; Paek D
Int Arch Allergy Immunol; 2010; 153(4):413-8. PubMed ID: 20559008
[TBL] [Abstract][Full Text] [Related]
33. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
Picard M; Giavina-Bianchi P; Mezzano V; Castells M
Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
[TBL] [Abstract][Full Text] [Related]
34. Spinal versus brain microglial and macrophage activation traits determine the differential neuroinflammatory responses and analgesic effect of minocycline in chronic neuropathic pain.
Li Z; Wei H; Piirainen S; Chen Z; Kalso E; Pertovaara A; Tian L
Brain Behav Immun; 2016 Nov; 58():107-117. PubMed ID: 27262531
[TBL] [Abstract][Full Text] [Related]
35. Minocycline Does Not Decrease Intensity of Neuropathic Pain Intensity, But Does Improve Its Affective Dimension.
Sumitani M; Ueda H; Hozumi J; Inoue R; Kogure T; Yamada Y; Kogure T
J Pain Palliat Care Pharmacother; 2016; 30(1):31-5. PubMed ID: 25700217
[TBL] [Abstract][Full Text] [Related]
36. Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases.
Espinosa E; Valitutti S; Laroche M; Laurent C; Apoil PA; Hermine O; Lavit M; Paul C; Bulai Livideanu C
Clin Immunol; 2018 Sep; 194():75-79. PubMed ID: 30004016
[TBL] [Abstract][Full Text] [Related]
37. Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications.
Cohen IV; Makunts T; Atayee R; Abagyan R
Sci Rep; 2017 May; 7(1):1450. PubMed ID: 28469132
[TBL] [Abstract][Full Text] [Related]
38. H1-antihistamines for primary mast cell activation syndromes: a systematic review.
Nurmatov UB; Rhatigan E; Simons FE; Sheikh A
Allergy; 2015 Sep; 70(9):1052-61. PubMed ID: 26095756
[TBL] [Abstract][Full Text] [Related]
39. [About the neuropathic component of back pain].
Komoly S
Ideggyogy Sz; 2012 May; 65(5-6):211-3. PubMed ID: 22724291
[No Abstract] [Full Text] [Related]
40. Systemic mastocytosis.
Karnam U; Rogers A
Dig Dis; 1999; 17(5-6):299-307. PubMed ID: 10838487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
